A L Caplan

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. doi request reprint Should patients in need be given access to experimental drugs?
    Arthur L Caplan
    NYU Langone Medical Center, Division of Medical Ethics, New York City, NY, USA 1 646 501 2514 1 646 501 2830
    Expert Opin Pharmacother 16:1275-9. 2015
  2. pmc Defining mental illnesses: can values and objectivity get along?
    Dominic Sisti
    Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, USA
    BMC Psychiatry 13:346. 2013
  3. doi request reprint Adverse event management in mass drug administration for neglected tropical diseases
    Arthur Caplan
    NYU, Langone Medical Center, New York, New York Electronic address
    Clin Ther 36:421-4. 2014
  4. doi request reprint Enhancing patient autonomy through peer review to replace the FDA's rigorous approval process
    Arthur Caplan
    Division of Bioethics, New York University Langone Medical Center, New York, NY, USA
    Health Aff (Millwood) 31:2236-40. 2012
  5. doi request reprint Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best
    A L Caplan
    Division of Medical Ethics, Langone Medical Center, New York University, New York, New York, USA
    Clin Pharmacol Ther 92:411-2. 2012

Collaborators

  • Dominic Sisti
  • Michael Young

Detail Information

Publications6

  1. doi request reprint Should patients in need be given access to experimental drugs?
    Arthur L Caplan
    NYU Langone Medical Center, Division of Medical Ethics, New York City, NY, USA 1 646 501 2514 1 646 501 2830
    Expert Opin Pharmacother 16:1275-9. 2015
    ..In this editorial, we discuss the impulse to rescue individual patients facing dire diseases and underscore the ethical questions that such rescue efforts raise. ..
  2. pmc Defining mental illnesses: can values and objectivity get along?
    Dominic Sisti
    Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, USA
    BMC Psychiatry 13:346. 2013
    ....
  3. doi request reprint Adverse event management in mass drug administration for neglected tropical diseases
    Arthur Caplan
    NYU, Langone Medical Center, New York, New York Electronic address
    Clin Ther 36:421-4. 2014
    ..Denying beneficial research interventions and MDA programs intended to benefit millions requires sound ethical justification based on more than the identification of and rote response to AEs and SAEs...
  4. doi request reprint Enhancing patient autonomy through peer review to replace the FDA's rigorous approval process
    Arthur Caplan
    Division of Bioethics, New York University Langone Medical Center, New York, NY, USA
    Health Aff (Millwood) 31:2236-40. 2012
    ..The hypothetical comparative effectiveness case study in this month's Health Affairs does not appear to rise to the level that would be helpful to providers or patients...
  5. doi request reprint Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best
    A L Caplan
    Division of Medical Ethics, Langone Medical Center, New York University, New York, New York, USA
    Clin Pharmacol Ther 92:411-2. 2012
    ..There also remain significant ethical and policy obstacles that may hinder the arrival of personalized medicine. The emergence of new prenatal genetic tests make the resolution of these ethical challenges imperative...